Regulatory Guidance for Drug Interaction Studies
SOLVO Transporter Studies for Regulatory Submission. Regulatory Requirements. SOLVO solutions and capabilities. Transporter Decision Trees.
Read More
- 63 transporters
- over 1500 references
- comprehensive information on holistic models and proteomics for transporter research
- changes in the regulatory landscape and scientific insights
- Full in Vitro DDI Package, Improved Hepatocyte Assays and more News & Developments!
- New Metabolism Service, Publications and Webinars from SOLVO!
- Webinar announcement - 21 March - Proteomics-informed Modeling Reveals Glucuronidation as a Transport Mechanism for Drugs and Endobiotics
- New Peer Reviewed Publications - SPOTLIGHT - Translatability of in vitro Inhibition Potency to in vivo P-Glycoprotein Mediated Drug Interaction Risk
Meet the Experts Transporter Conferences
As a pioneer in the drug transporter field for 20 years, SOLVO is dedicated to exploring the science of transporters and their role in xenobiotic efficacy and safety.
Budapest 2024 8-10, MayBranches
Request Consultancy Service, Questions about Products and Services, Media Relations, or General Inquiry use our Contact Form
Regulatory Guidance
Take home messages from the ITC papers
The potential for drug-drug interactions (DDIs) involving membrane transporters has become an area of intense regulatory review over the past seven years.
Read More